Digital Health in North America

The $2.1bn wager on machine-made medicine: why Isomorphic Labs may redraw the economics of drug discovery

Isomorphic Labs’ $2.1bn Series B is not simply another oversized AI funding round. It is a signal that investors now believe artificial…

June 9, 2026 by Julien de Salaberry Read article

Roche acquires PathAI: pharma partners face a vendor-risk problem

Roche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governance

May 26, 2026 by Julien de Salaberry Read article

AI in U.S. Healthcare Operations: Why Health Management Solutions Became the New Infrastructure Layer

Administrative overload, workforce shortages, and operating cost pressure have pushed U.S. healthcare beyond pilots: the United States now accounts for 41% of…

May 12, 2026 by Sara Schmachtenberg Read article

The American Powerplay: U.S. Digital Health Funding in Q1 2026

The United States absorbed 76% of global digital health funding in Q1 2026. Here's what the data actually says. TL;DR — U.S.…

April 14, 2026 by Galen Growth Read article

Rewiring Healthcare with the HealthTech 250 U.S. Cohort

TL;DR A Data-Driven Snapshot: This year’s HealthTech 250 U.S. cohort (data as of 1 Feb 2026) showcases 75 U.S.-based, early-stage (Pre-Seed to…

March 5, 2026 by Galen Growth Read article

Carbon Health: How a US$2.8bn Digital Health unicorn discovered clinics don’t scale like software

TL;DR Carbon Health filed for Chapter 11 protection on 2 February 2026 in the Southern District of Texas as a lender-backed “dual‑track”…

February 26, 2026 by Galen Growth Read article

U.S. Digital Health Funding 2025: The Year the Health System Took the Driver’s Seat

TL;DR Digital health funding reset: U.S. digital health funding reached $19.2 billion in 2025, shifting decisively toward provider-led, workflow-driven solutions with measurable…

January 29, 2026 by Galen Growth Read article

The Great Remote Patient Monitoring Reckoning: Why UnitedHealthcare’s Policy Change Demands a Systemic Digital Health Reset

UnitedHealthcare’s rollback of remote patient monitoring coverage is a pivotal market signal exposing the unsustainable economics of CPT-dependent RPM companies. Beyond the…

November 25, 2025 by Galen Growth Read article

TrumpRx Drug Price Mandate Disrupts Pharma’s Direct-to-Patient (DTP) Evolution: 3 Key Hypotheses

TrumpRx Drug Price Mandate Disrupts Pharma’s Direct-to-Patient (DTP) Evolution: 3 Key Hypotheses

November 18, 2025 by Galen Growth Read article

US Digital Health Q3 2025: Caution, Consolidation, and a New Clinical AI Order

US digital health in Q3 2025 traded hype for hard evidence: fewer deals, larger checks, and AI moving from feature to infrastructure.…

October 24, 2025 by Galen Growth Read article

HLTH USA 2025: Why Health Systems Are Driving the Digital Health Revolution

TL;DR For startups at HLTH USA 2025, Health Systems (Healthcare Providers) have become the most active partners, accounting for 30% of all…

October 16, 2025 by Galen Growth Read article

Who to Meet at HLTH USA 2025: Galen Growth’s Data-Led Playbook and Top 10 Series A Startups

An HLTH USA 2025 field guide for data-led networking and strategic dealmaking in digital health HLTH USA 2025 is the flagship health…

October 8, 2025 by Galen Growth Read article